ストックスクリーナーアプリを入手
13.42
0.15%
-0.02
アフターアワーズ：
13.42
Organon Co (OGN) 最新ニュース
Is TOFIDENCE’s Expanded CRS and COVID Label Altering The Investment Case For Organon (OGN)? - Yahoo Finance
Organon (OGN) director Shalini Sharp receives 17,857 phantom stock units as cash-settled award - Stock Titan
Organon (OGN) director Ramona Sequeira receives 17,857 phantom stock units as cash-settled award - Stock Titan
Organon (OGN) director receives 17.8K phantom stock units as compensation - Stock Titan
Organon (OGN) director granted cash-settled phantom stock tied to shares - Stock Titan
Organon (OGN) director awarded 17,857 phantom stock units as cash-settled compensation - Stock Titan
Organon (OGN) director receives phantom stock award, lifting holdings above 81,000 units - Stock Titan
Organon (OGN) director awarded 17,857 phantom stock units under savings plan - Stock Titan
Organon (OGN) director Alan Ezekowitz awarded 17,857 phantom stock units - Stock Titan
Organon (OGN) director awarded phantom stock units tied to shares - Stock Titan
Organon wins FDA nod to expand TOFIDENCE use in severe CRS & COVID-19 - MSN
Sun Pharma to acquire US-based Organon in nearly $11.75 billion deal - DD News
Press Release: Organon Reports Results for the First Quarter Ended March 31, 2026 - Moomoo
OGNOrganon & Co Stock Price and Quote - Finviz
Sun Pharma to buy Organon for $11.75B in record overseas deal - MSN
Organon & Co. Announces Results of 2026 Annual Meeting and Approves Incentive Stock Plan in Form 8-K Filing - Minichart
Organon Wins FDA Nod to Expand TOFIDENCE Use in Severe CRS & COVID-19 - Zacks Investment Research
Sector Gamma AS Has $2.15 Million Stock Position in Organon & Co. $OGN - MarketBeat
Private Management Group Inc. Acquires 1,204,979 Shares of Organon & Co. $OGN - MarketBeat
Organon & Co stock hits 52-week high at 13.48 USD - Investing.com Nigeria
Organon (NYSE: OGN) holders back amended 2021 incentive plan adding 8M shares - Stock Titan
Organon & Co. (NYSE:OGN) Sets New 1-Year HighStill a Buy? - MarketBeat
Brandes Investment Partners LP Has $4.35 Million Stock Holdings in Organon & Co. $OGN - MarketBeat
Organon & Co. (OGN) 10K Form and Latest SEC Filings 2026 - MarketBeat
Organon wins US approval to widen use of arthritis biosimilar drug - ETPharma.com
OGN News | ORGANON & CO (NYSE:OGN) - ChartMill
Sun Pharma seals $11.8 bn Organon deal, eyes global top 25 spot - MSN
SBI Set to Join Global Lenders Backing Sun Pharma's USD 12 Billion Organon Acquisition - Medical Dialogues
FDA expands Organon’s tocilizumab biosimilar indications - Investing.com UK
Organon & Co. (NYSE:OGN) Given Consensus Rating of "Reduce" by Brokerages - MarketBeat
Organon Expands Tofidence Label With FDA Approval for Additional Indications - marketscreener.com
FDA expands Organon’s tocilizumab biosimilar indications By Investing.com - Investing.com Australia
Organon Secures US Food and Drug Administration Approval Expanding Indications for TOFIDENCE - Business Wire
Halper Sadeh LLC is Investigating Whether NUVL, SUNE, OGN, TMHC are Obtaining Fair Deals for their Shareholders - GlobeNewswire Inc.
Organon & Co. (OGN) Is a Trending Stock: Facts to Know Before Betting on It - Yahoo Finance
SBI Set to Join Global Lenders in Funding Sun Pharma’s $12 Bn Organon Acquisition - outlookbusiness.com
SBI May Commit $1 Billion to Support Sun Pharma’s $12 Billion Organon Acquisition - India Infoline
SBI in $1 billion funding for Sun Pharma’s US deal - The Economic Times
What Sparked Organon's Recent Stock Surge - Kavout
(OGN) Risk Channels and Responsive Allocation - Stock Traders Daily
Sun Pharma to acquire Organon in US$11bn deal - FemTech World
OGN Stock Chart | ORGANON & CO (NYSE:OGN) - ChartMill
OGN Technical Analysis | Trend, Signals & Chart Patterns | ORGANON & CO (NYSE:OGN) - ChartMill
SHAREHOLDER NOTICE: Brodsky & Smith Announces an Investigation of Organon & Co. (OGN) - marketscreener.com
OGN CLASS ACTION NEWS: Organon & Co. Shareholders that Suffered Losses are Alerted of the Upcoming July 22 Securities Fraud Class Action Deadline - TMX Newsfile
OGN Stock Price, Quote & Chart | ORGANON & CO (NYSE:OGN) - ChartMill
Sun Pharma, Organon filed HSR May 21, waiting period expires June 22 - MLex
OGN Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
Organon (OGN) to be Acquired by Sun Pharma for $14.00 Cash per Share - Stock Titan
Sun Pharma bought the dip in its $11.7B Organon deal. Just not the right kind of dip - The Ken
Investors Heavily Search Organon & Co. (OGN): Here is What You Need to Know - Yahoo Finance
Organon (OGN) Holds Near Support at $13.35 as Stock ConsolidatesInsider Selling Alerts - thelegaladvocate.com
Organon & Co stock (US68622V1061): Shares trade quietly as investors await next catalysts - AD HOC NEWS
Organon & Co is the best performing healthcare stock in April - MSN
Hanmi Pharma partners with Organon to export combination therapies to Southeast Asia - BioSpectrum Asia
Organon & Co(OGN) Stock Options Chain | Quotes & News - Moomoo
0.15%
0.77%
大文字化:
|
ボリューム (24 時間):